Literature DB >> 15708922

ASessment in Ankylosing Spondylitis (ASAS) international working group: a model for psoriatic arthritis and psoriasis?

D van der Heijde1, J Braun, R Landewé, J Davis, J Sieper, S van der Linden, M Dougados.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15708922      PMCID： PMC1766884          DOI： 10.1136/ard.2004.030858

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

Review 1.  Ankylosing spondylitis: plenary discussion and results of voting on selection of domains and some specific instruments.

Authors:  D van der Heijde; S van der Linden; M Dougados; N Bellamy; A S Russell; J Edmonds
Journal:  J Rheumatol       Date:  1999-04       Impact factor: 4.666

Review 2.  Selection of instruments in the core set for DC-ART, SMARD, physical therapy, and clinical record keeping in ankylosing spondylitis. Progress report of the ASAS Working Group. Assessments in Ankylosing Spondylitis.

Authors:  D van der Heijde; A Calin; M Dougados; M A Khan; S van der Linden; N Bellamy
Journal:  J Rheumatol       Date:  1999-04       Impact factor: 4.666

Review 3.  International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis.

Authors:  J Braun; T Pham; J Sieper; J Davis; Sj van der Linden; M Dougados; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

4.  Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group.

Authors:  D van der Heijde; N Bellamy; A Calin; M Dougados; M A Khan; S van der Linden
Journal:  J Rheumatol       Date:  1997-11       Impact factor: 4.666

5.  Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis.

Authors:  J J Anderson; G Baron; D van der Heijde; D T Felson; M Dougados
Journal:  Arthritis Rheum       Date:  2001-08

6.  Initiation of biological agents in patients with ankylosing spondylitis: results of a Delphi study by the ASAS Group.

Authors:  T Pham; D van der Heijde; A Calin; M A Khan; Sj van der Linden; N Bellamy; M Dougados
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103
  6 in total
  1 in total

Review 1.  [Outcome parameters for use in psoriatic arthritis].

Authors:  J Braun; S Wassenberg
Journal:  Z Rheumatol       Date:  2006-03       Impact factor: 1.372
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.